	ASO Visual Abstract: Improving Clear Cell Renal Cell Carcinoma Diagnosis-Modified CT Algorithms with Simplified Heterogeneity Scoring. Ann Surg Oncol Zhang W, Chen Q, Zhu X, Li X, Wang X, Ma H, Song X, Zheng Z, Qu J. PMID: 42448979 [PubMed - as supplied by publisher]
	Neurokinin-1 receptor antagonism as a potential therapeutic strategy for cancer treatment; enhancing anti-tumor efficacy while mitigating treatment-related toxicities. NPJ Precis Oncol Maitra A, Muñoz M, Coveñas R, Hoang T, Italia Z, Robinson P. PMID: 42448885 [PubMed - as supplied by publisher]
	ddMVAC versus gemcitabine-cisplatin as neoadjuvant treatment for muscle-invasive urothelial bladder cancer: a multicenter real-world study. Sci Rep Malik M, Sigorski D, Jacyk P, Ró, Chowaniec Z, Ge, Ornat J, Tupikowski K, Maciejczyk A, Radecka B, Lewandowski T, Czerko K, Bodnar L, Kopczy, Ramlau R, Iwanik B, Ko, Piszczek R, Jab, Cybulska-Stopa B. PMID: 42448827 [PubMed - as supplied by publisher]
	Machine learning-based prognosis and early death prediction in de novo stage IV breast cancer patients with bone metastasis: a SEER database and multicentre retrospective study. Sci Rep Fang J, Wei M, Zhu T, Xu Z, Yu H, Yu T, Pi A, Shang X, Wang S, Fu P. PMID: 42448741 [PubMed - as supplied by publisher]
	Pharmaceutical Engineering of Lipid-Based Nanocarriers for Cancer Nanomedicines: From Doxorubicin to mRNA Platforms. ACS Biomater Sci Eng Gillman L, Suleski D, Graham ME, Ginn SL, Hassan MM. PMID: 42448603 [PubMed - as supplied by publisher]
	Navigating Psychosocial Challenges During Cancer Hospitalization: A Qualitative Study. Semin Oncol Nurs Ga, , Vrbnjak D. PMID: 42448516 [PubMed - as supplied by publisher]
	Re: De Luca et al. Primary Noncontrast Magnetic Resonance Imaging for Prostate Cancer Screening: A Randomized Clinical Trial (PROSA). Eur Urol 2026;89:246-57. Eur Urol Messina E, Sciarra A, La Torre G, Panebianco V. PMID: 42448494 [PubMed - as supplied by publisher]
	Comparison of circulating tumor DNA assays for molecular residual disease detection in non-small cell lung cancer. J Thorac Oncol Cui Q, Zhang JT, Yin H, Zhang KP, Xu J, Xu FP, Zhong WZ, Wu YL, Zhang QL. PMID: 42448176 [PubMed - as supplied by publisher]
	AdvanTIG-302: Phase 3 Study of Ociperlimab (Anti-TIGIT) + Tislelizumab (Anti-PD-1) Versus Pembrolizumab in Untreated, Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer With PD-L1 â‰¥50. J Thorac Oncol Socinski MA, Reck M, Paz-Ares L, Nishio M, Spira AI, Yu X, Melkadze T, Zeng A, Martinez-Bueno A, Li X, Arulananda S, Zuo Y, Chica-Duque S, Dai W, Zhou J, Tan W, Lu S. PMID: 42448175 [PubMed - as supplied by publisher]
	Applying Spiritual AIM with pediatric cancer patients and families: a composite case report. J Pain Symptom Manage Sheldon W, Berning J, Springer M, Kestenbaum A. PMID: 42448156 [PubMed - as supplied by publisher]
	Introducing Risk Stratification Reduces Patient Burden and Improves Cost-Effectiveness of Hepatocellular Carcinoma Surveillance for People with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Modelling Study. Value Health Worthington J, Kelly A, He E, George J, Adams LA, Feletto E. PMID: 42447982 [PubMed - as supplied by publisher]
	Retrospective cohort study on efficacy of extended treatment intervals of intralesional 5-fluorouracil in low-risk squamous cell carcinoma. J Am Acad Dermatol Hwang JC, Savage KT, Padmanabhan R, Pugliano-Mauro M. PMID: 42447959 [PubMed - as supplied by publisher]
	Arrhythmias in Patients with Cancer: Pathophysiology, Risk Stratification and Clinical Implications. Trends Cardiovasc Med Camilli M, Madaudo C, Tedeschi A, Rossi VA, Procureur A, Tamburrini G, Buono MGD, Imberti JF, Lombardo A, Novo G, Dent S, Boriani G, Cardinale DM, Minotti G. PMID: 42447942 [PubMed - as supplied by publisher]
	Availability and public reimbursement of early breast cancer care across European expert centres: a PORTRAIT from an EUSOMA initiative. Breast Bonci EA, Di Micco R, Marotti L, Miraldo M, Rubio IT, Curigliano G, Cardoso MJ, PORTRAIT Study Group. PMID: 42447838 [PubMed - as supplied by publisher]
	CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study. J Geriatr Oncol Schiza A, Fountzilas E, Biganzoli L, Digkas E, Fjermeros K, Geisler J, Karihtala P, Lindman H, Meattini I, Munoz-Mateu M, Risi E, Spathas N, Utriainen M, Visani L, Valachis A, Othman M. PMID: 42447829 [PubMed - as supplied by publisher]
	Role of frailty screening tools SCOPE-C and G8 in predicting surgical outcomes in older adults with head neck cancer in the Indian subcontinent: A prospective study. J Geriatr Oncol Kumar A, Kumar R, Sagar P, Kumar R, Khan MA, Thakar A, Sikka K, Singh CA, Panda S, Sood R, Mishra A. PMID: 42447827 [PubMed - as supplied by publisher]
	Engineering calcium-based nanoparticles for cancer treatment. Colloids Surf B Biointerfaces Costa M, Carvalho B, Sousa Â, Valente JFA, Patrício TMF. PMID: 42447758 [PubMed - as supplied by publisher]
	Muricadienin analogs as potent triggers of mitochondrial apoptosis and replicative stress in P53-deficient Cancer cells: A structure-activity relationship study. Bioorg Chem Tuktarova RA, Konkin PA, Dzhemilev UM, D'yakonov GV, Dzhemileva LU, D'yakonov VA. PMID: 42447747 [PubMed - as supplied by publisher]
	Quality of Life Endpoints in Advanced Gastrointestinal Cancer Trials: Systematic Review of Inclusion, Challenges, and Implications (2020-2024). Clin Oncol (R Coll Radiol) Kalantri S, Kelley B, Freeman JQ, Akhiwu TO, Redman R. PMID: 42447620 [PubMed - as supplied by publisher]
	Efficacy of doxorubicin-loaded graphene nanoplatform chemo-photothermal therapy versus photothermal therapy alone for breast cancer xenograft tumors: a meta-analysis. Int J Hyperthermia Gao HW, Li ZH, Lu Y, Fang YG, Shen FF, Song LW, Yu FZ. PMID: 42449201 [PubMed - in process]

Articles 1 - 20 / 1955113

Page 1 of 97756



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy